Juvenile myelomonocytic leukemia

Blood

Volumn 90, Issue 2, 1997, Pages 479-488

  Aricò, Maurizio ^a   Biondi, Andrea ^b   Pui, Ching Hon ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 10; MERCAPTOPURINE; PREDNISONE;

BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CACHEXIA; CANCER CHEMOTHERAPY; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; COLONY FORMING UNIT GM; DISEASE COURSE; ERYTHROPOIESIS; INFECTION; LEUKEMOGENESIS; LEUKOCYTE COUNT; LEUKOCYTOSIS; MONOCYTOSIS; MYELOMONOCYTIC LEUKEMIA; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; REMISSION; REVIEW; SPLENOMEGALY;

EID: 0030843626     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.2.479.479_479_488     Document Type: Review

References (103)

1. Eisenberg AA, Wallerstein H: Chronic myelosis in children. J Lab Clin Med 19:713, 1934
2. Cooke JV: Chronic myelogenous leukemia in children. J Pediatr 42:537, 1953
3. Bernard J, Mathe O, Delorme JC, Barnoud O: La leucemie myeloide chronique de l'enfant. Arch Fr Pediatr 19:881, 1962
4. Reisman LE, Trujillo JM: Chronic granulocytic leukemia of childhood. Clinical and cytogenetic studies. J Pediatr 62:710, 1963
5. Weatherall DJ, Edwards JA, Donohoe WTA: Hemoglobin and red cell enzymes changes in juvenile myeloid leukemia. BMJ 1:676, 1968
6. Hardisty RM, Speed DE, Till M: Granulocytic leukemia in childhood. Br J Haematol 10:551, 1964
7. Cao A: Juvenile chronic myeloid leukemia. Lancet 1:1002, 1970
8. Maurer HS, Vida LN, Honig GR: Similarities of the erythrocytes in Juvenile Chronic Myelogenous Leukemia to fetal erythropoiesis. Blood 39:778, 1972
9. Wheatherall DJ, Clegg JB, Wood WG: Foetal erythropoiesis in human leukemia. Nature 257:710, 1975
10. Weinberg RS, Leibowitz D, Weinblatt ME, Kochen J, Alter BP: Juvenile Chronic Myelogenous Leukemia: The only example of truly fetal (not fetal-like) erythropoiesis. Br J Haematol 76:307, 1990
11. Altman AJ, Palmer CG, Baehner RL: Juvenile "Chronic Granulocytic" Leukemia: A panmielopathy with prominent monocytic involvement and circulating monocyte colony-forming cells. Blood 43:341, 1974
12. Bennett M, Catovski D, Daniel MT, Flandrin G, Galton BAG, Gralnick H, Sultan C, Cox C: The chronic myeloid leukemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukemia. Proposals by the French-American-British Cooperative leukemia group. Br J Haematol 87:746, 1994
13. Lilleymann JS, Harrison JF, Black JA: Treatment of juvenile chronic myeloid leukemia with sequential subcutaneous cytarabine and oral mercaptopurine. Blood 49:559, 1977
14. Estrov Z, Grunberger T, Chan H, Freedman M: Juvenile chronic myelogenous leukemia: Characterization of the disease using cell cultures. Blood 67:1382, 1986
15. Castro-Malaspina H, Schaison G, Passe S, Pasquier A, Berger R, Bayle-Weisgerberg C, Miller D, Seligmann M, Bernard J: Subacute and chronic myelomonocytic leukemia in children (Juvenile CML). Clinical and hematologic observations, and identification of prognostic factors. Cancer 54:675, 1984
16. Sieff CA, Chessels JM, Harvey BAM. Pickthall VJ, Lawler SD: Monosomy 7 in childhood: A myeloproliferative disorder. Br J Haematol 49:235, 1981
17. Gyger M, Bonny Y, Forest L: Childhood monosomy 7 syndrome. Am J Hematol 13:329, 1982
18. Hasle H: Myelodysplastic syndromes in childhood-Classification, epidemiology, and treatment. Leuk Lymphoma 13:11, 1994
19. Niemeyer C, Aricò M, Basso G, Biondi A, Cantù Rajnoldi A, Creutzig U, Haas O, Harbott J, Hasle H, Kerndrup G, Locatelli F, Mann G, Stollmann-Gibbels B, Th Van't Veer-Korthof E, van Weering E, Zimmermann M and Members of the European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS): Chronic Myelomonocytic Leukemia in childhood: A retrospective analysis of 110 cases. Blood 89:3534, 1997
20. Passmore SJ, Hann IM, Stiller CA, Ramani P, Swansbury GJ, Gibbons B, Reeves BR, Chessels JM: Pediatric myelodysplasia: A study of 68 children and a new prognostic scoring system. Blood 85:1742, 1995
21. Haas OA, Gadner H: Pathogenesis, biology, and management of myelodysplastic syndromes in children. Semin Hematol 33:225, 1996
22. Iversen P, Rodwell RL, Pitcher L, Taylor KM, Lopez AF: Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R. Blood 86:2634, 1996
23. Emanuel PD, Shannon KM, Castleberry RP: Juvenile myelomonocytic leukemia: Molecular understanding and prospects for therapy. Molec Med Today 00:468, 1996
24. Hasle H, Jacobsen BB, Pedersen NT: Myelodysplastic syndromes in childhood: A population based study of nine cases. Br J Haematol 81:495, 1992
25. Royer B, Blondet C, Guilhard J: Xantholeucemie du nourisson et neurofibromatose de Recklinghausen. Ann Pediatr 5:260, 1958
26. Bader JL, Miller RW: Neurofibromatosis and childhood leukemia. J Pediatr 92:925, 1978
27. Stiller CA, Chessels JM, Fitchett M: Neurofibromatosis and childhood leukemia/lymphoma: A population-based UKCCSG study. Br J Cancer 70:969, 1994
28. Brandwein JM, Horsman DE, Eaves AC, Eaves CJ, Massing BG, Wadsworth LD, Rogers PCJ, Kalousek DK: Childhood myelodysplasia: Suggested classification as myelodysplastic syndromes based on laboratory and clinical findings. Am J Pediatr Hematol Oncol 12:63, 1990
29. Owen G, Lewis IJ, Morgan M, Robinson A, Stevens RF: Prognostic factors in juvenile chronic granulocytic leukemia. Br J Cancer 66:S68, 1992 (suppl XVIII)
30. Aricò M, Bossi G, Schirò R, Galimberti M, Longoni D, Macchia P, Miniero R, Natale D, Pession A, Pillon M, Santoro N, Tontoli N, Rusca MP, Biondi A for the AIEOP: Juvenile chronic myelogenous leukemia: Report of the Italian Registry. Hematologica 78:264, 1993
31. Donadieu J, Stephan JL, Blanche S, Cavazzana-Calvo M, Baruchel A, Herbelin C, Benkerrou M, Thomas C, Girault D, Fischer A: Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation. Bone Marrow Transplant 13:777, 1994
32. Chan H, Estrov Z, Weitzman S, Freedman MH: The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia. J Clin Oncol 5:1960, 1987
33. Festa R, Shende A, Lanzkowski P: Juvenile chronic myelocytic leukemia: Experience with intensive chemotherapy. Med Pediatr Oncol 18:311, 1990
34. Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S: Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 83:2248, 1994
35. Toren A, Mandel M, Amariglio N, Hakim Y, Brok-Simoni F, Rechavi G, Neumann Y, Ramot B: Lack of bcr rearrangement in juvenile chronic myeloid leukemia. Med Pediatr Oncol 19:493, 1991
36. Whetherall DJ, Brown MJ: Juvenile chronic myeloid leukemia: Lancet i:526, 1970
37. Hazani A, Barak Y, Berant M, Bar-Maor A: Congenital juvenile chronic myelogenous leukemia: Therapeutic trial with interferon alpha-2. Med Pediatr Oncol 21:73, 1993
38. Amenomori T, Tomonaga M, Yoshida Y, Kuriyama K, Matsuo T, Jinnai I, Ichimaru M, Omiya A, Tsuji Y: Cytogenetic evidence for partially committed myeloid progenitor cell origin of chronic myelomonocytic leukemia and juvenile chronic myeloid leukemia: Both granulocyte-macrophage precursors and erythroid precursors carry identical markers. Br J Haematol 64:539, 1986
39. Inoue S, Shibata T, Ravindranath Y, Gohle N: Clonal origin of erythroid cells in juvenile chronic myelogenous leukemia. Blood 69:975, 1987
40. Shannon KM, Watterson J, Johnson P, O'Connell P, Lange B, Shah N, Steinherz P, Kan YW, Priest JR: Monosomy 7 myeloproliferative disease in children with neurofibromatosis type 1 : Epidemiology and molecular analysis. Blood 79:1311, 1992
41. Kaneko Y, Maseki N, Sakurai M, Shibuya A, Shinohara T, Fujimoto T, Kanno H, Nishikawa A: Chromosome pattern in juvenile chronic myelogenous leukemia, myelodysplastic syndrome, and acute leukemia associated with neurofibromatosis. Leukemia 3:36, 1989
42. Case records of the Massachusetts General Hospital: Case 37-1994. N Engl J Med 331:1005, 1994
43. Massaad L, Prieur M, Leonard C, Dutrillaux B: Biclonal chromosome evolution of chronic myelomonocytic leukemia in a child. Cancer Genet Cytogenet 44:131, 1990
44. Rachmilevitz B, Rachmilevitz M: The clinical significance of serum transcobalamin in myeloid leukemia and other myeloproliferative disorders. Isr J Med Sci 13:710, 1977
45. Cannat A, Seligmann M: Immunoglobulin abnormalities in juvenile myelomonocytic leukemia. Br J Med 1:71, 1973
46. Puchkova GP, Prigogina EL, Fleishmann EV, Drosdova TS, Mayakova SA, Peterson IS: Chromosome abnormalities in chronic myeloid leukemia in children. Hum Genet 64:257, 1983
47. Ghione F, Mecucci C, Symann M, Michaux J-L, Casteels-Van Daele M, Van Den Berghe H: Cytogenetic investigations in childhood chronic myelocytic leukemia. Cancer Genet Cytogenet 20:317, 1986
48. Brodeur GM, Dow LW, Williams DL: Cytogenetic features of juvenile chronic myelogenous leukemia. Blood 53:812, 1979
49. Lau RC, Squire J, Brisson L, Kamel-Reid S, Grunberger T, Dubé I, Letarte M, Shannon K, Freedman M: Lymphoid blast crisis of B-lineage phenotype with monosomy 7 in a patient with juvenile chronic myelogenous leukemia (JCML). Leukemia 8:903, 1994
50. Pui CH, Aricò M: Isotretinoin for juvenile chronic myelogenous leukemia. N Engl J Med 332:1520, 1995
51. Suda T, Miura H, Mizoguchi H: Characterization of hemopoietic precursor cells in juvenile-type chronic myelocytic leukemia. Leuk Res 6:43, 1982
52. Emanuel P, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS: Selective hypersensitivity to granulocyte macrophage colony stimulating factor by juvenile chronic myeloid leukemia hemopoietic progenitors. Blood 77:925, 1991
53. Freedman M, Cohen A, Grunberger T, Bunin N, Luddy RE, Saunders EF, Shahidi N, Lau A, Estrov Z: Central role of tumor necrosis factor, GM-CSF, and interleukin-1 in the pathogenesis of juvenile chronic myelogenous leukemia. Br J Haematol 80:40, 1992
54. Bagby GC, Dinarello CA, Neerhout RC, Ridgway D, McCall E: Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type. J Clin Invest 82:1430, 1988
55. Emanuel PD, Bates LJ, Zu S-W, Castlebery R, Gualtieri RJ, Zuckerman KS: The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia. Exp Hematol 19:1017, 1991
56. Busque L, Gililand DG, Prchal JT, Sieff CA, Weinstein HJ, Sokol JM, Belickova M, Wayne AS, Zuckerman KS, Sokol L, Castleberry RP, Emanuel PD: Clonality in Juvenile chronic myelogenous leukemia. Blood 85:21, 1995
57. Lanfrancone L, Pelicci G, Brizzi MF, Arouica MG, Casciari C, Giuli S, Pegoraro L, Pawson T, Pelicci PG: Overexpression of the Shc proteins potentiates the proliferative response to the granulocyte-macropahge colony-stimulating factor and recruitment of Grb2/SoS and Grb2/p140 complexes to the B receptor subunit. Oncogene 10:907, 1995
58. Hirsch-Ginberg C, LeMaistre AC, Kantarjian H, Talpaz M, Cork A, Frereich EJ, Trujillo JM, Lee MS, Stass SA: RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia. Blood 76:1214, 1990
59. Tien H, Wang C-H, Chuang S-M, Chow J-M, Lee F-Y, Liu M-C, Chen Y-C, Shen M-C, Lin D-T, Lin K-H: Cytogenetic studies, ras mutation and clinical characteristics in primary myelodysplastic syndrome. A study of 68 Chinese patients in Taiwan. Cancer Genet Cytogenet 74:40, 1994
60. ras. Blood 84:3435, 1994
61. Shannon KM, O'Connell P, Martin G, Paderanga D, Olson K, Dinndorf P, McCormick F: Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597, 1994
62. Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange B, Freedman M, McCormick F, Jacks T, Shannon K: Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 12:144, 1996
63. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG: NF1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukemia. Nat Genet 12:137, 1996
64. Jack T, Shih S, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumorigenic and development consequences of a targeted nf1 in the mouse. Nat Genet 7:353, 1994
65. Quelle FW, Sato N, Witthuhun BA, Inhorn RC, Eder M, Miyajima A, Griffin JD, Ihle JN: JAK2 associates with the beta chain of the receptor for granulocyte-macrophage colony stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335, 1994
66. Schirò R, Longoni D, Rossi V, Maglia O, Doni A, Arsura M, Carrara G, Masera G, Vannier O, Dinarello CA, Biondi A: Suppression of juvenile chronic myelogenous leukemia colony growth factor by interleukin-1 receptor antagonist. Blood 83:460, 1994
67. Papayannopolou T, Nakamoto B, Anagnou NP, Chui D, Dow L, Sanders J: Expression of embryonic globins by erythroid cells in juvenile chronic myelocytic leukemia. Blood 77:2569, 1991
68. Privitera E, Schirò R, Longoni D, Ronchi A, Rambaldi A, Bernasconi S, Ottolenghi S, Masera G, Biondi A: Constitutive expression of GATA-1, EPOR, alfa-globin, and gamma-globin genes in myeloid clonogenic cells from juvenile chronic myelocytic leukemia. Blood 86:323, 1995
69. Miles DK, Feedman MH, Stephens K, Pallavicini M, Sievers EL, Weaver M, Grunberger T, Thompson P, Shannon KM: Pattern of hematopoietic lineage involvement in children with neurofibromatosis, type 1 and malignant myeloid disorders. Blood 88:4314, 1996
70. Fialkow PJ, Denman AM, Jacobson RJ, Lowenthal MN: Chronic myelocytic leukemia: Origin of some lymphocytes from leukemic stem cells. J Clin Invest 62:815, 1978
71. Lapidot T, Gruneberger T, Vormoor J, Estrov Z, Kollet O, Bunin N, Zaizov R, Williams DE, Freedman MH: Identification of human juvenile chronic myelogenous leukemic stem cells capable of initiating the disease in primary and secondary SCID mice. Blood 88:2655, 1996
72. Hutter SJ, Hecht F, Kaiser-McCaw B, Hays T, Baranko P, Cohen J, Durie B: Bone marrow monosomy 7: Hematologic and clinical manifestations in childhood and adolescence. Hematol Oncol 2:5, 1984
73. Freedman M, Estrov Z, Chan E: Juvenile chronic myelogenous leukemia. Am J Ped Hematol Oncol 10:261, 1988
74. Gadner H, Haas OA: Experience in pediatric myelodysplastic syndromes. Hematol Oncol North Am 6:655, 1992
75. Luna-Finemann S, Shannon K, Ortega J, Steinharz P, Davis J, Sanders J, Masterson M, Lange BJ: De novo childhood preleukemic conditions: Preliminary data from a retrospective study of 172 cases. Blood 86:51a, 1995
76. Butcher M, Frenck R, Emperor J, Paderanga D, Maybee D, Shannon K: Molecular evidence that childhood monosomy 7 syndrome is distinct from juvenile chronic myelogenous leukemia and other childhood myeloproliferative disorders. Genes Chromosom Cancer 12:50, 1995
77. Le Beau MM, Larson RA, Green ED, Shannon KM: Analysis of juvenile chronic myelogenous leukemia (JCML) bone marrows for submicroscopic deletions on 7q. Blood (in press)
78. Hasle H, Kerndrup G, Yssing M, Clausen N, Ostergaard E, Jacobsen N, Brock Jacobsen B: Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia 10:1269, 1996
79. Castleberry RP, Emanuel PD, Zuckerman KS, Cohn S, Strauss L, Byrd R, Homans A, Chaffee S, Nitschke R, Gualtieri RJ: A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. N Engl J Med 331:1680, 1994
80. Talpaz M, Kantarjian HM, McCredie K, Trujillo JM, Keating M, Gutterman JU: Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. N Engl J Med 314:1065, 1986
81. Maybee D, Dubow Krischer J, Buchnan G, Bowman W, Dickerman J, Hakami N, Laver J, Steuber P, Toledano S, Vietti T, Wilkinson R: Unusual toxicity of high dose alpha interferon in the treatment of juvenile chronic myelogenous leukemia. Proc Am Soc Clin Oncol 1:285, 1992 (abstr 950)
82. Shaw NJ, Eden OB: Juvenile chronic myelogenous leukemia and neurofibromatosis infancy presenting as ocular hemorrhage. Pediatr Hematol Oncol 6:23, 1989
83. Locatelli F, Niemeyer C, Angelucci E, Bender-Gotze C, Burdach S, Ebell W, Frederich W, Hasle H, Herman J, Jacobsen N, Klingebiel T, Kremens B, Mann G, Pession A,Peters C, Schmitd HJ, Stary J, Suttorp M, Uderzo C, Van 'T Veer-Korthof ET, Vosse J, Zecca M, Zimmermann M and members of the EWOG-MDS: Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on myelodysplastic Syndrome in Childhood (EWOG-MDS). J Clin Oncol 15:556, 1997
84. Locatelli F, Pession A, Bonetti F, Maserati E, Prete L, Pedrazzoli P, Zecca M, Prete A, Paolucci P, Cazzola M: Busulfan cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia 8:844, 1994
85. Rubie H, Attal M, Demur C, Brousset P, Duchayne E, Rigal-Huguet F, Dastugue N, Robert A: Intensified conditioning regimen with busulfan followed by allogeneic BMT in children with myelodysplasia. Bone Marrow Transplant 13:759, 1994
86. Akashi K: The role of interleukin-4 in the negative regulation of leukemia cell growth. Leuk Lymphoma 9:205, 1993
87. Geissler K, Öhler L, Födinger M, Virgolini I, Leimer M, Kabrna E, Kollars M, Skoupy S, Bohle B, Rogy M, Lechner K: Interleukin 10 inhibits growth and granulocyte macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells. J Exp Med 184:1, 1996
88. Gjeritsen MK, Bakka A, Breivik J, Saeterdal I, Solheim BG, Soereide O, Thorsby E, Gaudernack G: Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation. Lancet 346:1399, 1995
89. Gibb JB, Oliff A, Kohl NE: Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 77:175, 1994
90. Hancock JF: Anti-Ras drugs come of age. Curr Biol 3:770, 1993
91. Kohl N, Mosser S, deSolms S, Giuliani E, Pompliano D, Graham S, Smith R, Scolnick E, Oliff A, Gibbs JB: Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260:1934, 1993
92. James G, Goldstein J, Brown M, Rawson T, Somers T, McDowell R, Crowley C, Lucas B, Levinson A. Marsters J: Benzodiazepine peptidomimetics: Potent inhibitors of ras farnesylation in animal cells. Science 260:1937, 1993
93. Kohl NE, Wilson FR, Mosser SD, Giuliani E, DeSolms SJ, Conner MW, Anthony NJ, Holtz WJ, Gomez RP, Lee TJ, Smith RL, Graham SL, Hartman GD, Gibbs JB, Oliff A: Protein farnesyl-transferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc Natl Acad Sci USA 91:9141, 1994
94. Sepp-Lorenzino L, Ma Z, Rands E, Kohl NE, Gibbs JB, Oliff A, Rosen N: A peptidomimetic inhibitor of farnesyl protein transferase blocks the anchorage dependent and independent growth of human tumor cell lines. Cancer Res 55:5302, 1995
95. Casper J, Camitta B, Truitt R, Baxter-Lowe LA, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F, Keever-Taylor C, Drobyski W, Horowitz M, Flomenberg N, Ash R: Unrelated bone marrow donor transplant for children with leukemia or myelodysplasia. Blood 85:2354, 1995
96. Luna-Fineman S, Shannon KM, Lange BJ: Childhood monosomy 7: Epidemiology, biology, and mechanistic implications. Blood 85:1985, 1995
97. Sanders J, Buckner CD, Thomas ED, Fleischer R, Sullivan KM, Appelbaum FA, Storb R: Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood 71:1144, 1988
98. Bunin NJ, Casper JT, Lawton C, Murray K, Camilla B, Greenwood M, Geil J, Ash RC: Allogeneic bone marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings. Bone Marrow Transplant 9:119, 1992
99. Katz F, Hann I, Kinsey S, Ball S, Morgan G, Chessels J: Assessment of graft status following allogeneic bone marrow transplantation for haematological disorders in children using locus-specific minisatellite probes. Br J Haematol 83:473, 1993
100. Urban C, Schwinger W, Slave I, Schmid C, Gamillscheg A, Lackner H, Hauer C, Pakisch B: Busulfan/cyclophosphamide plus bone marrow transplantation is not sufficient to eradicate the malignant clone in juvenile chronic myelogenous leukemia. Bone Marrow Transplant 5:353, 1990
101. Peltier JY, Giralut D, Debre M, Galacteros F, Fischer A, Girot R: Donor for BMT with hemoglobin H disease. Bone Marrow Transplant 12:81, 1993
102. Jacobson BK, Kalayoglu M: Effective early treatment of hepatic venocclusive disease with a central splenorenal shunt in an infant. J Pediatr Surg 27:531, 1992
103. Rassam SMB, Katz F, Chessels JM, Morgan G: Successful allogeneic bone marrow transplantation in juvenile CML: Conditioning or graft-versus-leukemia effect? Bone Marrow Transplant 11:247, 1993